DENDRID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dendrid, and when can generic versions of Dendrid launch?
Dendrid is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in DENDRID is idoxuridine. There is one drug master file entry for this compound. Additional details are available on the idoxuridine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DENDRID?
- What are the global sales for DENDRID?
- What is Average Wholesale Price for DENDRID?
Summary for DENDRID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Patent Applications: | 6,382 |
| DailyMed Link: | DENDRID at DailyMed |
US Patents and Regulatory Information for DENDRID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | DENDRID | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 014169-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
